| Date Filed | Type | Description |
| 08/15/2023 |
4
| Banks Robert R. Jr. (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Bought 99 shares
@ $1.5, valued at
$148.5
Bought 1,901 shares
@ $1.6869, valued at
$3.2k
|
|
| 05/17/2023 |
3
| Banks Robert R. Jr. (President and CEO) has filed a Form 3 on NEPHROS INC |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Amron Arthur H (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 27,613 shares
@ $0
Granted 7,080 options to buy
@ $1.07, valued at
$7.6k
|
|
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2022 |
4
| Harris Joseph Michael (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 13,115 options to buy
@ $1.25, valued at
$16.4k
|
|
| 09/08/2022 |
3
| Harris Joseph Michael (Director) has filed a Form 3 on NEPHROS INC |
| 03/07/2022 |
4
| Astor Andrew (President, CEO & CFO) has filed a Form 4 on NEPHROS INC|
Txns:
| Exercised 14,815 warrants
@ $2.7, valued at
$40k
|
|
| 02/18/2022 |
4
| Lobo Wesley S. (Chief Marketing Officer) has filed a Form 4 on NEPHROS INC|
Txns:
| Paid exercise price by delivering 6,389 shares
@ $4.8, valued at
$30.7k
|
|
| 12/16/2021 |
4
| Lask Alisa (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 4,582 shares
@ $0
Granted 7,062 options to buy
@ $6.82, valued at
$48.2k
|
|
| 12/16/2021 |
4
| Gwydir Tom (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 4,582 shares
@ $0
Granted 7,062 options to buy
@ $6.82, valued at
$48.2k
|
|
| 12/16/2021 |
4
| Spandow Oliver J. (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 5,429 shares
@ $0
Granted 7,062 options to buy
@ $6.82, valued at
$48.2k
|
|
| 12/16/2021 |
4
| Amron Arthur H (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 4,582 shares
@ $0
Granted 7,062 options to buy
@ $6.82, valued at
$48.2k
|
|
| 12/16/2021 |
4
| Astor Andrew (President & CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 38,612 options to buy
@ $6.82, valued at
$263.3k
|
|
| 09/03/2021 |
4
| Lobo Wesley S. (Chief Commercial Officer) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 57,368 options to buy
@ $8.47, valued at
$485.9k
|
|
| 08/23/2021 |
4
| Lobo Wesley S. (Chief Marketing Officer) has filed a Form 4 on NEPHROS INC|
Txns:
| Bought 1,000 shares
@ $7.92, valued at
$7.9k
|
|
| 08/19/2021 |
4
| Gwydir Tom (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Bought 5,000 shares
@ $7.64, valued at
$38.2k
|
|
| 08/18/2021 |
4
| Astor Andrew (President & CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Bought 2,500 shares
@ $7.6687, valued at
$19.2k
Bought 2,500 shares
@ $7.7733, valued at
$19.4k
|
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4/A
| Evans Daron (CEO Specialty Renal Products) has filed a Form 4 on NEPHROS INC|
Txns:
| Paid exercise price by delivering 349 shares
@ $2.7, valued at
$942.3 |
|
| 05/25/2021 |
4
| Evans Daron (CEO of Specialty Renal Product) has filed a Form 4 on NEPHROS INC|
Txns:
| Exercised (in-or-at-the-money) 1,111 warrants
@ $2.7, valued at
$3k
|
|
| 02/18/2021 |
4
| Lobo Wesley S. (Chief Marketing Officer) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 40,557 shares
@ $0
Granted 114,178 options to buy
@ $8.66, valued at
$988.8k
|
|
| 02/18/2021 |
3
| Lobo Wesley S. (Chief Marketing Officer) has filed a Form 3 on NEPHROS INC |
| 01/29/2021 |
4
| WEXFORD CAPITAL LP (10% Owner) has filed a Form 4 on NEPHROS INC|
Txns:
| Exercised 3,556 options to buy
@ $4.59, valued at
$16.3k
Exercised 2,956 options to buy
@ $4.14, valued at
$12.2k
Exercised 3,765 options to buy
@ $3.6, valued at
$13.6k
Exercised 4,477 options to buy
@ $4.5, valued at
$20.1k
|
|
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Gwydir Tom (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 3,666 shares
@ $0
Granted 6,850 options to buy
@ $8.06, valued at
$55.2k
|
|
| 01/08/2021 |
4
| Lask Alisa (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 3,666 shares
@ $0
Granted 6,850 options to buy
@ $8.06, valued at
$55.2k
|
|
| 01/08/2021 |
4
| PERSEN MALCOLM C (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 5,921 shares
@ $0
Granted 6,850 options to buy
@ $8.06, valued at
$55.2k
|
|
| 01/08/2021 |
4
| Spandow Oliver J. (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 3,666 shares
@ $0
Granted 6,850 options to buy
@ $8.06, valued at
$55.2k
|
|
| 01/08/2021 |
4
| AMRON ARTHUR H (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 3,666 shares
@ $0
Granted 6,850 options to buy
@ $8.06, valued at
$55.2k
|
|
| 11/20/2020 |
4
| Spandow Oliver J. (Director) has filed a Form 4 on NEPHROS INC|
Txns:
| Bought 1,500 shares
@ $5.8328, valued at
$8.7k
|
|
| 11/19/2020 |
4
| Astor Andrew (President & CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Bought 1,000 shares
@ $5.8669, valued at
$5.9k
|
|
|